Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1
Common DSIP Peptide Claims Examined Most commercial claims extend beyond the available human evidence
Until rigorous studies show that BPC-157 does not awaken any sleeping dragons (like micrometastases), its best viewed with deep skepticism
BPC 157 accelerates the reconstruction of microvessels in damaged tissues by activating the VEGF pathway, thereby improving local blood circulation and accelerating the healing speed
Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
